2010
DOI: 10.1038/nature08825
|View full text |Cite
|
Sign up to set email alerts
|

ITPA gene variants protect against anaemia in patients treated for chronic hepatitis C

Abstract: Chronic infection with the hepatitis C virus (HCV) affects 170 million people worldwide and is an important cause of liver-related morbidity and mortality. The standard of care therapy combines pegylated interferon (pegIFN) alpha and ribavirin (RBV), and is associated with a range of treatment-limiting adverse effects. One of the most important of these is RBV-induced haemolytic anaemia, which affects most patients and is severe enough to require dose modification in up to 15% of patients. Here we show that ge… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

30
457
11
4

Year Published

2011
2011
2018
2018

Publication Types

Select...
5
3

Relationship

1
7

Authors

Journals

citations
Cited by 423 publications
(502 citation statements)
references
References 27 publications
30
457
11
4
Order By: Relevance
“…Patients who are heterozygous for rs1127354 and rs7270101 have a lower risk for Hb drop > 3 g/dl during antiviral therapy [10]. This association was confirmed in our study for allelic and genotypic rs1127354 variants.…”
Section: Discussionsupporting
confidence: 86%
See 2 more Smart Citations
“…Patients who are heterozygous for rs1127354 and rs7270101 have a lower risk for Hb drop > 3 g/dl during antiviral therapy [10]. This association was confirmed in our study for allelic and genotypic rs1127354 variants.…”
Section: Discussionsupporting
confidence: 86%
“…Among those 194 patients were from the Swiss Hepatitis C Cohort Study (SCCS) [22] al. [10], i.e. wildtype (100% ITPA activity), + (rs7270101 heterozygosity, 60% IPTA activity), ++ (rs1127354 heterozygosity and rs727101 homozygosity, 30% ITPA activity) and +++ (combined heterozygosity or rs1127354 homozygosity, very low residual ITPA activity.…”
Section: Study Design and Patientsmentioning
confidence: 99%
See 1 more Smart Citation
“…24 ITPA genotyping could help guide clinical decision-making, especially for patients in whom treatment with RBV is avoided or relatively contraindicated because of the high risk for developing anemia.…”
Section: Clinical Role For Pharmacogenetics In Hepatitis Cmentioning
confidence: 99%
“…In this work we investigate a local joint-testing approach to analysis of genetic data sets in which pairs of variants from the same locus are examined simultaneously for association with a phenotype. The motivation for our approach comes from the mounting evidence that complex traits are highly polygenic (Visscher et al 2012), that causal variants are not evenly distributed across the genome (Gusev et al 2013), that known associated loci often harbor multiple causal variants (Udler et al 2009;Fellay et al 2010;Trynka et al 2011;Wood et al 2011;Liu et al 2012;Patsopoulos et al 2013;Pickrell 2014), and that the underlying causal variants can be in linkage disequilibrium (LD) with each other (Corradin et al 2014).…”
mentioning
confidence: 99%